IMARC Group, a leading market research company, has recently released a report titled "Bioresorbable Polymers Market Size, Share, Trends and Forecast by Product, Application, and Region, 2025-2033" The study provides a detailed analysis of the industry, including the global bioresorbable polymers market size, share, growth, trends, and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Bioresorbable Polymers Market Overview

The global bioresorbable polymers market was valued at USD 1.62 Billion in 2024 and is projected to reach USD 3.77 Billion by 2033, growing at a CAGR of 9.37% during the forecast period from 2025 to 2033. North America leads the market with over 33.5% share in 2024, driven by healthcare industry growth, chronic disease prevalence, and demand from orthopedic and drug delivery applications. Advanced polymer innovations and R&D activities further fuel the market expansion.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Bioresorbable Polymers Market Key Takeaways

• Current Market Size: USD 1.62 Billion in 2024
• CAGR: 9.37%
• Forecast Period: 2025-2033
• North America dominates the market with over 33.5% share in 2024.
• Orthopedics is the leading application with around 44.5% market share in 2024.
• Polylactic acid (PLA) leads the product segment with approximately 28.9% market share in 2024.
• Increasing prevalence of chronic diseases and demand for minimally invasive surgeries drive market growth.
• Rising research and development investments and regulatory support boost innovation and adoption.

Request Your Free “Bioresorbable Polymers Market” Insights Sample PDF: https://www.imarcgroup.com/bioresorbable-polymers-market/requestsample

Market Growth Factors

The bioresorbable polymers market is driven by the growing demand for advanced medical devices and its application in drug delivery systems, in tissue engineering and as a surgical implant, due to increase in prevalence of chronic diseases across the globe and the increase in adoption of minimally intrusive surgeries (MIS). For instance, Zeus Inc. launched Absorv™ XSE-oriented tubing to fill the gap of permanent metallic stents in September 2023, improving device design and performance while achieving better clinical outcomes.

The market is also driven by technological advances by being able to improve biocompatibility and biodegradability of polymers, and thereby extending their applications into orthopedics and cardiovascular devices. The use of bioresorbable metal implants has been approved by the FDA for Bioretec Ltd in March 2023. Increasing investments in the healthcare industry are also expected to propel the growth of the bioresorbable implants market.

Besides medical applications, the global trend towards more sustainable materials creates a market for bioresorbable polymers as an alternative to conventional plastics in packaging, automotive, and agriculture. An example is Solvay's Naternal family (introduced in June 2023), which for hair and skin care consists of biodegradable polymers, illustrating the expansion of applications and demand and regulatory pressure factors.

Market Segmentation

Breakup by Product:

• Polysaccharides: Naturally derived polymers valued for biodegradability and diverse biomedical applications.
• Proteins: Bio-based polymers used in tissue engineering and drug delivery due to biocompatibility.
• Polylactic Acid: Leading polymer with 28.9% market share in 2024, known for biocompatibility, biodegradability, and versatile healthcare applications.
• Polyglycolic Acid: Used in medical devices for controlled degradation and compatibility.
• Polycaprolactone: A biodegradable polymer used in long-term implants and drug delivery systems.
• Others: Includes various bioresorbable polymers used across medical and non-medical industries.

Breakup by Application:

• Drug Delivery: Utilizes polymers for controlled release and biodegradable delivery systems.
• Orthopedics: Dominant application with 44.5% market share in 2024, applied in bone fixation, implants, and surgical treatments reducing the need for removal surgeries.
• Others: Encompasses additional applications including cardiovascular devices and wound healing.

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America is the leading region for bioresorbable polymers, accounting for over 33.5% market share in 2024. The strong healthcare infrastructure, high demand for advanced medical technologies, and preference for minimally invasive surgeries contribute to this leadership. The U.S. specifically represents 82.50% of North American market revenue, supported by increasing chronic disease cases and significant healthcare expenditure of USD 4.3 trillion in 2021.